GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Insmed Inc (NAS:INSM) » Definitions » E10

Insmed (Insmed) E10 : $-3.83 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Insmed E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Insmed's adjusted earnings per share data for the three months ended in Dec. 2023 was $-1.280. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-3.83 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was -11.30% per year. During the past 5 years, the average E10 Growth Rate was -23.90% per year. During the past 10 years, the average E10 Growth Rate was -11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Insmed was 44.30% per year. The lowest was -57.50% per year. And the median was 10.45% per year.

As of today (2024-04-25), Insmed's current stock price is $24.975. Insmed's E10 for the quarter that ended in Dec. 2023 was $-3.83. Insmed's Shiller PE Ratio of today is .


Insmed E10 Historical Data

The historical data trend for Insmed's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Insmed E10 Chart

Insmed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.50 -2.78 -3.01 -3.39 -3.83

Insmed Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.39 -3.51 -3.69 -3.77 -3.83

Competitive Comparison of Insmed's E10

For the Biotechnology subindustry, Insmed's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Insmed's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Insmed's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Insmed's Shiller PE Ratio falls into.



Insmed E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Insmed's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1.28/129.4194*129.4194
=-1.280

Current CPI (Dec. 2023) = 129.4194.

Insmed Quarterly Data

per share eps CPI Adj_EPS
201403 -0.360 99.695 -0.467
201406 -0.590 100.560 -0.759
201409 -0.540 100.428 -0.696
201412 -0.360 99.070 -0.470
201503 -0.550 99.621 -0.715
201506 -0.470 100.684 -0.604
201509 -0.500 100.392 -0.645
201512 -0.510 99.792 -0.661
201603 -0.540 100.470 -0.696
201606 -0.590 101.688 -0.751
201609 -0.610 101.861 -0.775
201612 -1.100 101.863 -1.398
201703 -0.600 102.862 -0.755
201706 -0.720 103.349 -0.902
201709 -0.690 104.136 -0.858
201712 -0.850 104.011 -1.058
201803 -0.890 105.290 -1.094
201806 -1.000 106.317 -1.217
201809 -1.140 106.507 -1.385
201812 -1.190 105.998 -1.453
201903 -0.960 107.251 -1.158
201906 -0.810 108.070 -0.970
201909 -0.680 108.329 -0.812
201912 -0.590 108.420 -0.704
202003 -0.740 108.902 -0.879
202006 -0.640 108.767 -0.762
202009 -0.630 109.815 -0.742
202012 -1.000 109.897 -1.178
202103 -0.890 111.754 -1.031
202106 -1.070 114.631 -1.208
202109 -0.960 115.734 -1.074
202112 -0.950 117.630 -1.045
202203 -0.800 121.301 -0.854
202206 -0.800 125.017 -0.828
202209 -1.090 125.227 -1.126
202212 -1.210 125.222 -1.251
202303 -1.170 127.348 -1.189
202306 -1.780 128.729 -1.790
202309 -1.110 129.860 -1.106
202312 -1.280 129.419 -1.280

Add all the adjusted EPS together and divide 10 will get our e10.


Insmed  (NAS:INSM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Insmed E10 Related Terms

Thank you for viewing the detailed overview of Insmed's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Insmed (Insmed) Business Description

Traded in Other Exchanges
Address
700 US Highway 202/206, Bridgewater, NJ, USA, 08807
Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.
Executives
Flammer Martina M.d. officer: Chief Medical Officer 700 US HIGHWAY 202/206, BRIDGEWATER NJ 08807
Roger Adsett officer: Chief Commercial Officer 10 FINDERNE AVENUE, BRIDGEWATER NJ 08807
John Drayton Wise officer: Chief Commercial Officer 700 US HIGHWAY 202/206, BRIDGEWATER NJ 08807
Michael Alexander Smith officer: General Counsel, Senior VP 700 US HIGHWAY 202/206, BRIDGEWATER NJ 08807
William Lewis officer: President & CEO 10 FINDERNE AVENUE, BUILDING 10, BRIDGEWATER NJ 08807
Schaeffer Orlov S Nicole officer: Chief People Strategy Officer INSMED INCORPORATED, 10 FINDERNE AVENUE, BRIDGEWATER NJ 08807
Sara Bonstein officer: Chief Financial Officer 305 COLLEGE ROAD EAST, PRINCETON NJ 08540
Melvin Md Sharoky director 10 FINDERNE AVENUE, BUILDING 10, BRIDGEWATER NJ 08807
Leo Lee director 10 FINDERNE AVENUE, BRIDGEWATER NJ 08807
David R Brennan director C/O INSMED INCORPORATED, 10 FINDERNE AVENUE, BRIDGEWATER NJ 08807
Steinar J Engelsen director 10 FINDERNE AVENUE, BUILDING 10, BRIDGEWATER NJ 08807
John Soriano officer: Chief Compliance Officer 10 FINDERNE AVENUE, BRIDGEWATER NJ 08807
Christine A Pellizzari officer: General Counsel & Secretary 10 FINDERNE AVENUE, BRIDGEWATER NJ 08807
Alfred Altomari director C/O AGILE THERAPEUTICS, INC., 101 POOR FARM ROAD, PRINCETON NJ 08540
Elizabeth M Anderson director 10 FINDERNE AVENUE, BUILDING 10, BRIDGEWATER NJ 08807